Sensitivity, Reproducibility and Clinical Utility Of Next-Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain Mutation Screening: Results From The CML Work Package Of The Iron-II (Interlaboratory RObustness Of Next-Generation Sequencing) International Study

Konference: 2013 55th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 604. Molecular Pharmacology, Drug Resistance: Poster III

Číslo abstraktu: 3824

Autoři: Simona Soverini; MD Thomas Ernst; Dr. Alexander Kohlmann, PhD; Caterina De Benedittis; Mary Alikian; MD Letizia Foroni, PhD; Mgr. Kateřina Machová (Poláková), Ph.D.; Ing. Adéla Benešová (Broučková), Ph.D.; Yucel Erbilgin; Ozden Hatirnaz; prof. MD Ugur Ozbek, PhD.; Cristina Robledo; MD Jesus Hernandez; Ing. Milena Musilová, Ph.D.; Santiago Barrio, Ph.D.; Dr. Joaquin Martinez-Lopez, M.D., Ph.D.; Renate Kastner; Prof. MD Thomas Lion, PhD; MD Torsten Haferlach; MD Andreas Hochhaus; Prof.MD Giovanni Martinelli

Datum přednesení příspěvku: 9. 12. 2013